University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Pandha, H"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 229.

Article

Lophatananon, Artitaya, Stewart-Brown, Sarah, Kote-Jarai, Zsofia, Olama, Ali Amin Al, Garcia, Sara Benlloch, Neal, David E, Hamdy, Freddie C, Donovan, Jenny L, Giles, Graham G, Fitzgerald, Liesel M, Southey, Melissa C, Pharoah, Paul, Pashayan, Nora, Gronberg, Henrik, Wiklund, Fredrik, Aly, Markus, Stanford, Janet L, Brenner, Hermann, Dieffenbach, Aida K, Arndt, Volker, Park, Jong Y, Lin, Hui-Yi, Sellers, Thomas, Slavov, Chavdar, Kaneva, Radka, Mitev, Vanio, Batra, Jyotsna, Spurdle, Amanda, Clements, Judith A, Schleutker, Johanna, Nordestgaard, BØrge G, Wiklund, Fredrik, Travis, Ruth C, Haiman, Christopher A, Thibodeau, Stephen N, Maier, Christiane, Walther, Vogel, Blot, William J, Kibel, Adam S, Cybulski, Cezary, Cannon-Albright, Lisa, Pandha, Hardev, Teixeira, Manuel R, Cook, Margaret, Govindasami, Koveela, Guy, Michelle, Leongamornlert, Daniel, Sawyer, Emma J, Wilkinson, Rosemary, Morgan, Angela, Fisher, Cyril, Saunders, Edward J, Tymrakiewicz, Malgorzata, Livni, Naomi, Hazel, Steve, Dadaev, Tokhir, Cox, Angela, George, Anne, Lane, Athene, Marsden, Gemma, Davis, Michael, Brown, Paul, Pedersen, John, Hopper, John L, Karlsson, Ami, Cavalli-Bjoerkman, Carin, Adolfson, Jan, Johansson, Jan-Erik, Broms, Michael, Stattin, Paer, Kolb, Suzanne, Stegmaier, Christa, Zachariah, Babu, Park, Hyun, Haley, James, Pow-Sang, Julio, Rincon, Maria, Radlein, Selina, Vlahova, Aleksandrina, Mitkova, Atanaska, Kachakova, Darina, Popov, Elenko, Christova, Svetlana, Dikov, Tihomir, Eckert, Allison, Collins, Angus, Wood, Glenn, Malone, Greg, Alexander, Kimberly, Kerr, Kris, Kedda, Mary-Anne, Turner, Megan, Saunders, Pamela, Heathcote, Peter, Srinivasan, Srilakshmi, Omara, Tracy, Yeadon, Trina, Lose, Felicity, Easton, Douglas, Eeles, Rosalind A and Muir, Kenneth (2017) Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium British Journal of Cancer, 117 (5). pp. 734-743.

Walker, SM, Knight, LA, McCavigan, AM, Logan, GE, Berge, V, Sherif, A, Pandha, Hardev, Warren, AY, Davidson, C, Uprichard, A, Blayney, JK, Price, B, Jellema, GL, Svindland, A, McDade, SS, Eden, CG, Foster, C, Mills, IG, Neal, DE, Mason, MD, Kay, EW, Waugh, DJ, Harkin, DP, Watson, RW, Clarke, NW and Kennedy, RD (2017) Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology European Urology, 72 (4). pp. 509-518.

Gogalic, S, Sauer, U, Doppler, S, Heinzel, A, Perco, P, Lukas, A, Simpson, Guy, Pandha, Hardev, Horvath, A and Preininger, C (2017) Validation of a protein panel for the non-invasive detection of recurrent non-muscle invasive bladder cancer Biomarkers.

Taylor, AE, Martin, RM, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Pashayan, N, Khaw, KT, Blott, W, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon‐Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, HS, PRACTICAL Consortium, ., Donovan, J and Munafo, MR (2016) Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis International Journal of Cancer.

Ravaud, A, Motzer, RJ, Pandha, HS, George, DJ, Pantuck, AJ, Patel, A, Chang, YH, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M, Lin, X, Martini, JF, Ramaswamy, K, Casey, M, Staehler, M and Patard, JJ (2016) Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy New England Journal of Medicine.

Bonilla, C, Lewis, SJ, Rowlands, M, Gaunt, TR, Davey Smith, G, Gunnell, D, Palmer, T, Donovan, JL, Hamdy, FC, Neal, DE, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Pashayan, N, Khaw, K, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, HS, PRACTICAL consortium, , Lathrop, M, Martin, RM and Holly, JMP (2016) Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: genetic variants as instruments for circulating levels International Journal of Cancer, 139 (7). pp. 1520-1533.

Larkin, SET, Johnston, HE, Jackson, TR, Jamieson, DG, Roumeliotis, TI, Mockridge, CI, Manousopoulou, A, Papachristou, EK, Brown, MD, Clarke, NW, Pandha, HS, Aukim-Hastie, CL, Cragg, MS, Garbis, SD and Townsend, PA (2016) Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study British Journal of Cancer.

Brunner, C, Davies, NM, Martin, RM, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, G, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Donovan, J, Hamdy, FC, Pashayan, N, Khaw, KT, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, HS, PRACTICAL Consortium, and Zuccolo, L (2016) Alcohol Consumption and Prostate Cancer Incidence and Progression: a Mendelian Randomization Study International Journal of Cancer.

Kar, SP, Beesley, J, Al Olama, AA, Michailidou, K, Tyrer, J, Kote-Jarai, ZA, Lawrenson, K, Lindstrom, S, Ramus, SJ, Thompson, DJ, Kibel, AS, Dansonka-Mieszkowska, A, Michael, A, Dieffenbach, AK, Gentry-Maharaj, A, Whittemore, AS, Wolk, A, Monteiro, A, Peixoto, A, Kierzek, A, Cox, A, Rudolph, A, Gonzalez-Neira, A, Wu, AH, Lindblom, A, Swerdlow, A, Ziogas, A, Ekici, AB, Burwinkel, B, Karlan, BY, Nordestgaard, BG, Blomqvist, C, Phelan, C, McLean, C, Pearce, CL, Vachon, C, Cybulski, C, Slavov, C, Stegmaier, C, Maier, C, Ambrosone, CB, Hogdall, CK, Teerlink, CC, Kang, D, Tessier, DC, Schaid, DJ, Stram, DO, Cramer, DW, Neal, DE, Eccles, D, Flesch-Janys, D, Edwards, DRV, Wokozorczyk, D, Levine, DA, Yannoukakos, D, Sawyer, EJ, Bandera, EV, Poole, EM, Goode, EL, Khusnutdinova, E, Hogdall, E, Song, F, Bruinsma, F, Heitz, F, Modugno, F, Hamdy, FC, Wiklund, F, Giles, GG, Olsson, H, Wildiers, H, Ulmer, H-U, Pandha, H, Risch, HA, Darabi, H, Salvesen, HB, Nevanlinna, H, Gronberg, H, Brenner, H, Brauch, H, Anton-Culver, H, Song, H, Lim, H-Y, McNeish, I, Campbell, I, Vergote, I, Gronwald, J, Lubinski, J, Stanford, JL, Bentez, J, Doherty, JA, Permuth, JB, Chang-Claude, J, Donovan, JL, Dennis, J, Schildkraut, JM, Schleutker, J, Hopper, JL, Kupryjanczyk, J, Park, JY, Figueroa, J, Clements, JA, Knight, JA, Peto, J, Cunningham, JM, Pow-Sang, J, Batra, J, Czene, K, Lu, KH, Herkommer, K, Khaw, K-T, Matsuo, K, Muir, K, Offitt, K, Chen, K, Moysich, KB, Aittomaki, K, Odunsi, K, Kiemeney, LA, Massuger, LFAG, Fitzgerald, LM, Cook, LS, Cannon-Albright, L, Hooning, MJ, Pike, MC, Bolla, MK, Luedeke, M, Teixeira, MR, Goodman, MT, Schmidt, MK, Riggan, M, Aly, M, Rossing, MA, Beckmann, MW, Moisse, M, Sanderson, M, Southey, MC, Jones, M, Lush, M, Hildebrandt, MAT, Hou, M-F, Schoemaker, MJ, Garcia-Closas, M, Bogdanova, N, Rahman, N, Le, ND, Orr, N, Wentzensen, N, Pashayan, N, Peterlongo, P, Guenel, P, Brennan, P, Paulo, P, Webb, PM, Broberg, P, Fasching, PA, Devilee, P, Wang, Q, Cai, Q, Li, Q, Kaneva, R, Butzow, R, Kopperud, RK, Schmutzler, RK, Stephenson, RA, MacInnis, RJ, Hoover, RN, Winqvist, R, Ness, R, Milne, RL, Travis, RC, Benlloch, S, Olson, SH, McDonnell, SK, Tworoger, SS, Maia, SA, Berndt, S, Lee, SC, Teo, S-H, Thibodeau, SN, Bojesen, SE, Gapstur, SM, Kjaer, SK, Pejovic, T, Tammela, TLJ, Doerk, T, Bruening, T, Wahlfors, T, Key, TJ, Edwards, TL, Menon, U, Hamann, U, Mitev, V, Kosma, V-M, Setiawan, VW, Kristensen, V, Arndt, V, Vogel, W, Zheng, W, Sieh, W, Blot, WJ, Kluzniak, W, Shu, X-O, Gao, Y-T, Schumacher, F, Freedman, ML, Berchuck, A, Dunning, AM, Simard, J, Haiman, CA, Spurdle, A, Sellers, TA, Hunter, DJ, Henderson, BE, Kraft, P, Chanock, SJ, Couch, FJ, Hall, P, Gayther, SA, Easton, DF, Chenevix-Trench, G, Eeles, R, Pharoah, PDP and Lambrechts, D (2016) Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types CANCER DISCOVERY, 6 (9). pp. 1052-1067.

De Paoli, M, Gogalic, S, Sauer, U, Preininger, C, Pandha, HS, Simpson, G, Horvath, A and Marquette, C (2016) Multi-platform biomarker discovery for bladder cancer recurrence diagnosis Disease Markers, 4591910.

Khankari, NK, Murff, HJ, Zeng, C, Wen, W, Eeles, RA, Easton, DF, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Donovan, JL, Pashayan, N, Khaw, K, Stanford, JL, Blot, WJ, Thibodeau, SN, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, HS and Zheng, W (2016) Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomization analysis from the PRACTICAL consortium British Journal of Cancer.

Kelly, Z, Moller-Levet, Carla, McGrath, S, Butler-Manuel, S, Madhuri, Thumuluru, Kierzek, Andrzej, Pandha, Hardev, Morgan, Richard and Michael, Agnieszka (2016) The prognostic significance of specific HOX gene expression patterns in ovarian cancer International Journal of Cancer, 139 (7). pp. 1608-1617.

Bull, CJ, Bonilla, C, Holly, JM, Perks, CM, Davies, N, Haycock, P, Yu, OH, Richards, JB, Eeles, R, Easton, D, Kote-Jarai, Z, Amin Al Olama, A, Benlloch, S, Muir, K, Giles, GG, MacInnis, RJ, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Pashayan, N, Khaw, KT, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Micheal, A, Pandha, H, Smith, GD, Lewis, SJ and Martin, RM (2016) Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer medicine, 5 (6). pp. 1125-1136.

Crea, F, Quagliata, L, Michael, A, Liu, HH, Frumento, P, Azad, AA, Xue, H, Pikor, L, Watahiki, A, Morant, R, Eppenberger-Castori, S, Wang, Y, Parolia, A, Lennox, KA, Lam, WL, Gleave, M, Chi, KN, Pandha, H, Wang, Y and Helgason, CD (2016) Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression MOLECULAR ONCOLOGY, 10 (5). pp. 693-703.

Gusev, A, Shi, H, Kichaev, G, Pomerantz, M, Li, F, Long, HW, Ingles, SA, Kittles, RA, Strom, SS, Rybicki, BA, Nemesure, B, Isaacs, WB, Zheng, W, Pettaway, CA, Yeboah, ED, Tettey, Y, Biritwum, RB, Adjei, AA, Tay, E, Truelove, A, Niwa, S, Chokkalingam, AP, John, EM, Murphy, AB, Signorello, LB, Carpten, J, Leske, MC, Wu, S-Y, Hennis, AJM, Neslund-Dudas, C, Hsing, AW, Chu, L, Goodman, PJ, Klein, EA, Witte, JS, Casey, G, Kaggwa, S, Cook, MB, Stram, DO, Blot, WJ, Eeles, RA, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Southey, MC, Fitzgerald, LM, Gronberg, H, Wiklund, F, Aly, M, Henderson, BE, Schleutker, J, Wahlfors, T, Tammela, TLJ, Nordestgaard, BG, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, K-T, Stanford, JL, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Teerlink, C, Brenner, H, Dieffenbach, AK, Arndt, V, Park, JY, Sellers, TA, Lin, H-Y, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Spurdle, A, Clements, JA, Teixeira, MR, Pandha, HS, Michael, A, Paulo, P, Maia, S, Kierzek, A, Conti, DV, Albanes, D, Berg, C, Berndt, SI, Campa, D, Crawford, ED, Diver, WR, Gapstur, SM, Gaziano, JM, Giovannucci, E, Hoover, R, Hunter, DJ, Johansson, M, Kraft, P, Le Marchand, L, Lindstrom, S, Navarro, C, Overvad, K, Riboli, E, Siddiq, A, Stevens, VL, Trichopoulos, D, Vineis, P, Yeager, M, Trynka, G, Raychaudhuri, S, Schumacher, FR, Price, AL, Freedman, ML, Haiman, CA, Pasaniuc, B, Cook, M, Guy, M, Govindasami, K, Leongamornlert, D, Sawyer, EJ, Wilkinson, R, Saunders, EJ, Tymrakiewicz, M, Dadaev, T, Morgan, A, Fischer, C, Hazel, S, Livni, N, Lophatananon, A, Pedersen, J, Hopper, JL, Adolfson, J, Stattin, P, Johansson, J-E, Cavalli-Bjoerkman, C, Karlsson, A, Broms, M, Auvinen, A, Kujala, P, Maeaettaenen, L, Murtola, T, Taari, K, Weischer, M, Nielsen, SF, Klarskov, P, Roder, A, Iversen, P, Wallinder, H, Signorello, LB, Blot, WJ, Tillmans, L, Riska, S, Wang, L, Rinckleb, A, Lubiski, J, Stegmaier, C, Pow-Sang, J, Park, H, Radlein, S, Rincon, M, Haley, J, Zachariah, B, Kachakova, D, Popov, E, Mitkova, A, Vlahova, A, Dikov, T, Christova, S, Heathcote, P, Wood, G, Malone, G, Saunders, K, Eckert, A, Yeadon, T, Kerr, K, Collins, A, Turner, M, Srinivasan, S, Kedda, M-A, Alexander, K, Omara, T, Wu, H, Henrique, R, Pinto, P, Santos, J and Barros-Silva, J (2016) Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation Nature Communications, 7.

Bonilla, C, Lewis, SJ, Martin, RM, Donovan, JL, Hamdy, FC, Neal, DE, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Pashayan, N, Khaw, KT, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, H, Lathrop, M, Davey Smith, G and Consortium, PRACTICAL (2016) Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Medicine, 14 (1). pp. 66-76.

Saunders, EJ, Dadaev, T, Leongamornlert, DA, Olama, AA, Benlloch, S, Giles, GG, Wiklund, F, Grönberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Pasayan, N, Khaw, KT, Stanford, JL, Blot, WJ, Thibodeau, SN, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, JY, Kaneva, R, Batra, J, Teixeira, MR, Pandha, H, Govindasami, K, Muir, K, Genetic Prostate Cancer Study Collaborators, UK, ProtecT Study Collaborators, UK, Consortium, PRACTICAL, Easton, DF, Eeles, RA and Kote-Jarai, Z (2016) Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer, 114. pp. 945-952.

Morgan, R, Simpson, G, Gray, S, Gillett, C, Tabi, Z, Spicer, J, Harrington, KJ and Pandha, HS (2016) HOX transcription factors are potential targets and markers in malignant mesothelioma BMC CANCER, 16, ARTN 85.

Relph, KL, Pandha, H, Simpson, GR, Melcher, A and Harrington, K (2016) Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Oncolytic Virotherapy, 2016 (5). pp. 1-13.

Rajani, K, Parrish, C, Kottke, T, Thompson, J, Zaidi, S, Ilett, L, Shim, KG, Diaz, R-M, Pandha, H, Harrington, K, Coffey, M, Melcher, A and Vile, R (2016) Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses MOLECULAR THERAPY, 24 (1). pp. 166-174.

Blanchard, M, Shim, KG, Grams, MP, Rajani, K, Diaz, RM, Furutani, KM, Thompson, J, Olivier, KR, Park, SS, Markovic, SN, Pandha, H, Melcher, A, Harrington, K, Zaidi, S and Vile, R (2015) Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93 (3). pp. 577-587.

Szulkin, R, Karlsson, R, Whitington, T, Aly, M, Gronberg, H, Eeles, RA, Easton, DF, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Southey, MC, FitzGerald, LM, Henderson, BE, Schumacher, FR, Haiman, CA, Sipeky, C, Tammela, TLJ, Nordestgaard, BG, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, PDP, Pashayan, N, Khaw, K-T, Stanford, JL, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Lubinski, J, Kluzniak, W, Cannon-Albright, L, Brenner, H, Herrmann, V, Holleczek, B, Park, JY, Sellers, TA, Lim, H-Y, Slavov, C, Kaneva, RP, Mitev, VI, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Batra, J, Clements, JA, Albanes, D, Andriole, GL, Berndt, SI, Chanock, S, Gapstur, SM, Giovannucci, EL, Hunter, DJ, Kraft, P, Le Marchand, L, Ma, J, Mondul, AM, Penney, KL, Stampfer, MJ, Stevens, VL, Weinstein, SJ, Trichopoulou, A, Bueno-de-Mesquita, BH, Tjonneland, A, Cox, DG, Maehle, L, Schleutker, J, Lindstroem, S and Wiklund, F (2015) Genome-Wide Association Study of Prostate Cancer-Specific Survival CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24 (11). pp. 1796-1800.

Davies, NM, Gaunt, TR, Lewis, SJ, Holly, J, Donovan, JL, Hamdy, FC, Kemp, JP, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Pashayan, N, Khaw, K-T, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, H, Lathrop, M, Smith, GD and Martin, RM (2015) The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium CANCER CAUSES & CONTROL, 26 (11). pp. 1603-1616.

Al Olama, AA, Dadaev, T, Hazelett, DJ, Li, Q, Leongamornlert, D, Saunders, EJ, Stephens, S, Cieza-Borrella, C, Whitmore, I, Garcia, SB, Giles, GG, Southey, MC, Fitzgerald, L, Gronberg, H, Wiklund, F, Aly, M, Henderson, BE, Schumacher, F, Haiman, CA, Schleutker, J, Wahlfors, T, Tammela, TL, Nordestgaard, BG, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, K-T, Stanford, JL, Thibodeau, SN, Mcdonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Brenner, H, Butterbach, K, Arndt, V, Park, JY, Sellers, T, Lin, H-Y, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Govindasami, K, Guy, M, Lophatonanon, A, Muir, K, Vinuela, A, Brown, AA, Freedman, M, Conti, DV, Easton, D, Coetzee, GA, Eeles, RA and Kote-Jarai, Z (2015) Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans HUMAN MOLECULAR GENETICS, 24 (19). pp. 5589-5602.

Szulkin, R, Whitington, T, Eklund, M, Aly, M, Eeles, RA, Easton, D, Kote-Jarai, Z, Al Olama, AA, Benlloch, S, Muir, K, Giles, GG, Southey, MC, Fitzgerald, LM, Henderson, BE, Schumacher, F, Haiman, CA, Schleutker, J, Wahlfors, T, Tammela, TLJ, Nordestgaard, BG, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, K-T, Stanford, JL, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Lubinski, J, Kluzniak, W, Cannon-Albright, L, Brenner, H, Butterbach, K, Stegmaier, C, Park, JY, Sellers, T, Lim, H-Y, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Gronberg, H and Wiklund, F (2015) Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score PROSTATE, 75 (13). pp. 1467-1474.

Pandha, H and Pawelec, G (2015) Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015 CANCER IMMUNOLOGY IMMUNOTHERAPY, 64 (9). pp. 1071-1074.

Michael, A, Coward, J, Brown, A, Barber, N and Pandha, H (2015) The Tolerability of Sunitinib in Elderly Patients with Metastatic Renal Cancer CLINICAL ONCOLOGY, 27 (6). pp. 371-372.

Roulstone, V, Pedersen, M, Kyula, J, Mansfield, D, Khan, AA, McEntee, G, Wilkinson, M, Karapanagiotou, E, Coffey, M, Marais, R, Jebar, A, Errington-Mais, F, Melcher, A, Vile, R, Pandha, H, McLaughlin, M and Harrington, KJ (2015) BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress MOLECULAR THERAPY, 23 (5). pp. 931-942.

Zaidi, S, Blanchard, M, Shim, K, Ilett, E, Rajani, K, Parrish, C, Boisgerault, N, Kottke, T, Thompson, J, Celis, E, Pulido, J, Selby, P, Pandha, H, Melcher, A, Harrington, K and Vile, R (2015) Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine melanoma Model After Treatment With Immunomodulatory Agents MOLECULAR THERAPY, 23 (5). pp. 845-856.

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

Enting, D, Iannitto, ML, Pandha, H, Chowdhury, S and Hayday, A (2015) Effects of Concomitant Therapies on gamma delta T Cell Responses to Zoledronate in Patients with Advanced Prostate Cancer CLINICAL ONCOLOGY, 27 (3). E4-E4.

Seth, R, Khan, AA, Pencavel, TD, Wilkinson, MJ, Kyula, JN, Simpson, G, Pandha, H, Melcher, A, Vile, R, Harris, PA and Harrington, KJ (2015) Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus-Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma PLASTIC AND RECONSTRUCTIVE SURGERY, 135 (2). pp. 475-487.

De Paoli, M, Perco, P, Muehlberger, I, Lukas, A, Pandha, H, Morgan, R, Feng, GJ and Marquette, C (2015) Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic BIOMARKERS, 20 (5). pp. 328-337.

Appleton, ES, Turnbull, S, Ralph, C, West, E, Scott, K, Harrington, K, Pandha, H and Melcher, A (2015) Talimogene laherparepvec in the treatment of melanoma EXPERT OPINION ON BIOLOGICAL THERAPY, 15 (10). pp. 1517-1530.

McGrath, SE, Michael, A, Morgan, R and Pandha, H (2015) EN2 in Prostate Cancer. Adv Clin Chem, 71. pp. 47-76.

Alonso-Camino, V, Rajani, K, Kottke, T, Rommelfanger-Konkol, D, Zaidi, S, Thompson, J, Pulido, J, Ilett, E, Donnelly, O, Selby, P, Pandha, H, Melcher, A, Harrington, K, Diaz, RM and Vile, R (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site MOLECULAR THERAPY, 22 (11). pp. 1936-1948.

Errico, MC, Felicetti, F, Bottero, L, Mattia, G, Felli, N, Petrini, M, Bellenghi, M, Pandha, HS, Morgan, R and Care, A (2014) THE ABROGATION OF THE HOXB7/PBX2 COMPLEX INDUCES APOPTOSIS IN MELANOMA THROUGH THE MIR-221&222-c-FOS PATHWAY ANTICANCER RESEARCH, 34 (10). pp. 5895-5896.

Ilett, E, Kottke, T, Donnelly, O, Thompson, J, Willmon, C, Diaz, R, Zaidi, S, Coffey, M, Selby, P, Harrington, K, Pandha, H, Melcher, A and Vile, R (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus MOLECULAR THERAPY, 22 (10). pp. 1851-1863.

Michael, A, Kelly, ZL, Moller-Levet, CS, Pandha, H and Morgan, R (2014) HOX GENE EXPRESSION IN OVARIAN CANCER ANTICANCER RESEARCH, 34 (10). pp. 6058-6059.

Morgan, R, Gray, S, Gillett, C, Tabi, Z, Launchbury, F, Spicer, J, Harrington, K and Pandha, HS (2014) HOX TRANSCRIPTION FACTORS ARE POTENTIAL TARGETS AND MARKERS IN MALIGNANT MESOTHELIOMA ANTICANCER RESEARCH, 34 (10). pp. 6069-6071.

Daniels, TR, Neacato, II, Rodriguez, JA, Pandha, HS, Morgan, R and Penichet, ML (2014) TARGETING THE HOX TRANSCRIPTION FACTORS AND CD71 IN MULTIPLE MYELOMA ANTICANCER RESEARCH, 34 (10). pp. 6107-6108.

Al Olama, AA, Kote-Jarai, Z, Berndt, SI, Conti, DV, Schumacher, F, Han, Y, Benlloch, S, Hazelett, DJ, Wang, Z, Saunders, E, Leongamornlert, D, Lindstrom, S, Jugurnauth-Little, S, Dadaev, T, Tymrakiewicz, M, Stram, DO, Rand, K, Wan, P, Stram, A, Sheng, X, Pooler, LC, Park, K, Xia, L, Tyrer, J, Kolonel, LN, Le Marchand, L, Hoover, RN, Machiela, MJ, Yeager, M, Burdette, L, Chung, CC, Hutchinson, A, Yu, K, Goh, C, Ahmed, M, Govindasami, K, Guy, M, Tammela, TLJ, Auvinen, A, Wahlfors, T, Schleutker, J, Visakorpi, T, Leinonen, KA, Xu, J, Aly, M, Donovan, J, Travis, RC, Key, TJ, Siddiq, A, Canzian, F, Khaw, K-T, Takahashi, A, Kubo, M, Pharoah, P, Pashayan, N, Weischer, M, Nordestgaard, BG, Nielsen, SF, Klarskov, P, Roder, MA, Iversen, P, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Stanford, JL, Kolb, S, Holt, S, Knudsen, B, Coll, AH, Gapstur, SM, Diver, WR, Stevens, VL, Maier, C, Luedeke, M, Herkommer, K, Rinckleb, AE, Strom, SS, Pettaway, C, Yeboah, ED, Tettey, Y, Biritwum, RB, Adjei, AA, Tay, E, Truelove, A, Niwa, S, Choklcalingam, AP, Cannon-Albright, L, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Park, J, Sellers, T, Lin, H-Y, Isaacs, WB, Partin, AW, Brenner, H, Dieffenbach, AK, Stegmaier, C, Chen, C, Giovannucci, EL, Ma, J, Stampfer, M, Penney, KL, Mucci, L, John, EM, Ingles, SA, Kittles, RA, Murphy, AB, Pandha, H, Michael, A, Kierzek, AM, Blot, W, Signorello, LB, Zheng, W, Albanes, D, Virtamo, J, Weinstein, S, Nemesure, B, Carpten, J, Leske, C, Wu, S-Y, Hennis, A, Kibel, AS, Rybicki, BA, Neslund-Dudas, C, Hsing, AW, Chu, L, Goodman, PJ, Klein, EA, Zheng, SL, Batra, J, Clements, J, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Slavov, C, Kaneva, R, Mitev, V, Witte, JS, Casey, G, Gillanders, EM, Seminara, D, Riboli, E, Hamdy, FC, Coetzee, GA, Li, Q, Freedman, ML, Hunter, DJ, Muir, K, Gronberg, H, Nea, DE, Southey, M, Giles, GG, Severi, G, Cook, MB, Nakagawa, H, Wiklund, F, Kraft, P, Chanock, SJ, Henderson, BE, Easton, DF, Eeles, RA and Haiman, CA (2014) A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer NATURE GENETICS, 46 (10). pp. 1103-1109.

Annels, NE, Simpson, GR, Denyer, M, McGrath, SE, Falgari, G, Killick, E, Eeles, R, Stebbing, J, Pchejetski, D, Cutress, R, Murray, N, Michael, A and Pandha, H (2014) Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 177 (2). pp. 428-438.

de Bono, JS, Piulats, JM, Pandha, HS, Petrylak, DP, Saad, F, Aparicio, LMA, Sandhu, SK, Fong, P, Gillessen, S, Hudes, GR, Wang, T, Scranton, J and Pollak, MN (2014) Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer CLINICAL CANCER RESEARCH, 20 (7). pp. 1925-1934.

Kyula, JN, Khan, AA, Mansfield, D, Karapanagiotou, EM, Mclaughlin, M, Roulstone, V, Zaidi, S, Pencavel, T, Touchefeu, Y, Seth, R, Chen, NG, Yu, YA, Zhang, Q, Melcher, AA, Vile, RG, Pandha, HS, Ajaz, M, Szalay, AA and Harrington, KJ (2014) Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling Oncogene, 33 (13). pp. 1700-1712.

Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F and Melcher, AA (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites INTERNATIONAL JOURNAL OF CANCER, 134 (5). pp. 1091-1101.

Morgan, R, Boxall, A, Harrington, KJ, Simpson, GR, Michael, A and Pandha, HS (2014) Targeting HOX transcription factors in prostate cancer BMC UROLOGY, 14, ARTN 1.

Michael, Agnieszka, Relph, Kate, Annels, Nicola and Pandha, Hardev (2014) Prostate cancer vaccines. Expert Review of Vaccines, 12 (3). pp. 253-262.

Kottke, T, Boisgerault, N, Diaz, RM, Donnelly, O, Rommelfanger-Konkol, D, Pulido, J, Thompson, J, Mukhopadhyay, D, Kaspar, R, Coffey, M, Pandha, H, Melcher, A, Harrington, K, Selby, P and Vile, R (2013) Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence NATURE MEDICINE, 19 (12). pp. 1625-1631.

McGrath, SE, Michael, A, Morgan, R and Pandha, H (2013) EN2: a novel prostate cancer biomarker. Biomark Med, 7 (6). pp. 893-901.

Annels, NE, Shaw, VE, Gabitass, RF, Billingham, L, Corrie, P, Eatock, M, Valle, J, Smith, D, Wadsley, J, Cunningham, D, Pandha, H, Neoptolemos, JP and Middleton, G (2013) The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer. Cancer Immunol Immunother.

Errico, MC, Felicetti, F, Bottero, L, Mattia, G, Boe, A, Felli, N, Petrini, M, Bellenghi, M, Pandha, HS, Calvaruso, M, Tripodo, C, Colombo, MP, Morgan, R and Care, A (2013) The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway INTERNATIONAL JOURNAL OF CANCER, 133 (4). pp. 879-892.

Boisgerault, N, Kottke, T, Pulido, J, Thompson, J, Diaz, RM, Rommelfanger-Konkol, D, Embry, A, Saenz, D, Poeschla, E, Pandha, H, Harrington, K, Melcher, A, Selby, P and Vile, R (2013) Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse MOLECULAR THERAPY, 21 (8). pp. 1507-1516.

Donnelly, O, Harrington, K, Melcher, A and Pandha, H (2013) Live viruses to treat cancer JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 106 (8). pp. 310-314.

Comins, C, Simpson, GR, Relph, K, Harrington, KJ, Melcher, A and Pandha, H (2013) Reoviral Therapy for Cancer: Strategies for Improving Antitumor Efficacy Using Radio- and Chemotherapy pp. 185-198.

Michael, A and Pandha, H (2013) Presentation and symptomatology of prostate cancer pp. 467-471.

Alharbi, RA, Pandha, HS, Morgan, R and Pettengell, R (2013) The role of HOX genes in normal hematopoiesis and acute leukemia Leukemia, 27 (5). pp. 1000-1008.

McGrath, SE, Michael, A, Pandha, H and Morgan, R (2013) Engrailed homeobox transcription factors as potential markers and targets in cancer. FEBS Lett, 587 (6). pp. 549-554.

Ross, ADM, Cook, MG, Chong, H, Hossain, M, Pandha, HS and Bennett, DC (2013) Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression PIGMENT CELL & MELANOMA RESEARCH, 26 (2).

Morgan, Richard, Bryan, RT, Javed, S, Launchbury, F, Zeegers, MP, Cheng, KK, James, ND, Wallace, DM, Hurst, CD, Ward, DG, Knowles, MA and Pandha, Hardev (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. Eur J Cancer.

Killick, E, Morgan, R, Launchbury, F, Bancroft, E, Page, E, Castro, E, Kote-Jarai, Z, Aprikian, A, Blanco, I, Clowes, V, Domchek, S, Douglas, F, Eccles, D, Evans, DG, Harris, M, Kirk, J, Lam, J, Lindeman, G, Mitchell, G, Pachter, N, Selkirk, C, Tucker, K, Zgajnar, J, Eeles, R and Pandha, H (2013) Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Sci Rep, 3.

Alharbi, RA, Pettengell, R, Pandha, HS and Morgan, R (2012) The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia.

Adair, RA, Scott, KJ, Fraser, S, Errington-Mais, F, Pandha, H, Coffey, M, Selby, P, Cook, GP, Vile, R, Harrington, KJ, Toogood, G and Melcher, AA (2012) Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells. Int J Cancer.

Morgan, Richard, Boxall, A, Simpson, Guy, Michael, Agnieszka, Pandha, Hardev, Harrington, KJ and Gillett, C (2012) Targeting the HOX/PBX dimer in breast cancer Breast Cancer Research and Treatment, 136 (2). pp. 389-398.

Morgan, R, Boxall, A, Harrington, KJ, Simpson, GR, Gillett, C, Michael, A and Pandha, HS (2012) Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res Treat, 136 (2). pp. 389-398.

Pandha, H, Sorensen, KD, Orntoft, TF, Langley, S, Hoyer, S, Borre, M and Morgan, R (2012) Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer. BJU Int, 110 (6 Pt B). E287-E292.

Mansfield, D, Pencavel, T, Kyula, JN, Zaidi, S, Roulstone, V, Thway, K, Karapanagiotou, L, Khan, AA, McLaughlin, M, Touchefeu, Y, Seth, R, Melcher, AA, Vile, RG, Pandha, HS and Harrington, KJ (2012) Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral Oncol.

Roulstone, V, Twigger, K, Zaidi, S, Pencavel, T, Kyula, JN, White, C, McLaughlin, M, Seth, R, Karapanagiotou, EM, Mansfield, D, Coffey, M, Nuovo, G, Vile, RG, Pandha, HS, Melcher, AA and Harrington, KJ (2012) Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther.

Donnelly, O, Vile, R, Pandha, H, Harrington, K and Melcher, A (2012) The hitchhiker's guide to virotherapy. Oncotarget, 3 (8). pp. 735-736.

Tuan, J, Pandha, H, Corbishley, C and Khoo, V (2012) Basaloid carcinoma of the prostate: A literature review with case report Indian Journal of Urology, 28 (3). pp. 322-324.

Adair, RA, Roulstone, V, Scott, KJ, Morgan, R, Nuovo, GJ, Fuller, M, Beirne, D, West, EJ, Jennings, VA, Rose, A, Kyula, J, Fraser, S, Dave, R, Anthoney, DA, Merrick, A, Prestwich, R, Aldouri, A, Donnelly, O, Pandha, H, Coffey, M, Selby, P, Vile, R, Toogood, G, Harrington, K and Melcher, AA (2012) Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci Transl Med, 4 (138).

Karapanagiotou, EM, Roulstone, V, Twigger, K, Ball, M, Tanay, M, Nutting, C, Newbold, K, Gore, ME, Larkin, J, Syrigos, KN, Coffey, M, Thompson, B, Mettinger, K, Vile, RG, Pandha, HS, Hall, GD, Melcher, AA, Chester, J and Harrington, KJ (2012) Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies CLINICAL CANCER RESEARCH, 18 (7). pp. 2080-2089.

Pulido, J, Kottke, T, Thompson, J, Galivo, F, Wongthida, P, Diaz, RM, Rommelfanger, D, Ilett, E, Pease, L, Pandha, H, Harrington, K, Selby, P, Melcher, A and Vile, R (2012) Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma Nature Biotechnology, 30 (4). pp. 337-343.

Simpson, GR, Horvath, A, Annels, NE, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, RS, Mostafid, H, Melcher, AA, Harrington, KJ and Pandha, HS (2012) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer BRITISH JOURNAL OF CANCER, 106 (3). pp. 496-507.

Middleton, GW, Annels, NE and Pandha, HS (2012) Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? Cancer Immunol Immunother, 61 (1). pp. 1-7.

Hall, K, Scott, KJ, Rose, A, Desborough, M, Harrington, K, Pandha, H, Parrish, C, Vile, R, Coffey, M, Bowen, D, Errington-Mais, F and Melcher, AA (2012) Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia. Biores Open Access, 1 (1). pp. 3-15.

Twigger, K, Roulstone, V, Kyula, J, Karapanagiotou, EM, Syrigos, KN, Morgan, R, White, C, Bhide, S, Nuovo, G, Coffey, M, Thompson, B, Jebar, A, Errington, F, Melcher, AA, Vile, RG, Pandha, HS and Harrington, KJ (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer, 12.

Donnelly, OG, Errington-Mais, F, Steele, L, Hadac, E, Jennings, V, Scott, K, Peach, H, Phillips, RM, Bond, J, Pandha, H, Harrington, K, Vile, R, Russell, S, Selby, P and Melcher, AA (2011) Measles virus causes immunogenic cell death in human melanoma. Gene Ther.

Metcalf, S, Pandha, HS and Morgan, R (2011) Antiangiogenic effects of zoledronate on cancer neovasculature. Future Oncol, 7 (11). pp. 1325-1333.

Donnelly, OG, Errington-Mais, F, Prestwich, R, Harrington, K, Pandha, H, Vile, R and Melcher, AA (2011) Recent Clinical Experience With Oncolytic Viruses. Curr Pharm Biotechnol.

Kottke, T, Errington, F, Pulido, J, Galivo, F, Thompson, J, Wongthida, P, Diaz, RM, Chong, H, Ilett, E, Chester, J, Pandha, H, Harrington, K, Selby, P, Melcher, A and Vile, R (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med, 17 (7). pp. 854-859.

Hamdan, S, Verbeke, CS, Fox, N, Booth, J, Bottley, G, Pandha, HS and Blair, GE (2011) The roles of cell surface attachment molecules and coagulation Factor X in adenovirus 5-mediated gene transfer in pancreatic cancer cells. Cancer Gene Ther, 18 (7). pp. 478-488.

Gabitass, RF, Annels, NE, Stocken, DD, Pandha, HA and Middleton, GW (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother.

Michael, A, Riley, C, Bokaee, S, Denyer, M, Pandha, HS and Annels, NE (2011) EN2: A candidate antigen for the development of targeted therapies in ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Gabitass, RF, Annels, NE, Crawshaw, J, Pandha, HS and Middleton, GW (2011) Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Ilett, EJ, Barcena, M, Errington-Mais, F, Griffin, S, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Limpens, RWAL, Mommaas, M, Hoeben, RC, Vile, RG and Melcher, AA (2011) Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization CLINICAL CANCER RESEARCH, 17 (9). pp. 2767-2776.

Morgan, R, Boxall, A, Bhatt, A, Bailey, M, Hindley, R, Langley, S, Whitaker, HC, Neal, DE, Ismail, M, Whitaker, H, Annels, N, Michael, A and Pandha, H (2011) Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer CLINICAL CANCER RESEARCH, 17 (5). pp. 1090-1098.

Morgan, RM, Ismail, M, Boxall, A, Bhaat, A, Hindley, R, Michael, A, Langley, SM, Zylstra, J and Pandha, HS (2011) ENGRAILED-2 (EN2): A HIGHLY SPECIFIC URINARY BIOMARKER FOR THE EARLY DIAGNOSIS OF PROSTATE CANCER EUR UROL SUPPL, 10 (2). p. 64.

Steele, L, Errington, F, Prestwich, R, Ilett, E, Harrington, K, Pandha, H, Coffey, M, Selby, P, Vile, R and Melcher, A (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming MOLECULAR CANCER, 10, ARTN 20.

Kelly, ZL, Michael, Agnieszka, Butler-Manuel, S, Pandha, Hardev and Morgan, Richard (2011) HOX genes in ovarian cancer Journal of Ovarian Research, 4 (1).

Gray, S, Pandha, HS, Michael, A, Middleton, G and Morgan, R (2011) HOX genes in pancreatic development and cancer. JOP, 12 (3). pp. 216-219.

Heinemann, L, Simpson, GR, Boxall, A, Kottke, T, Relph, KL, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ, Morgan, R and Pandha, HS (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11.

Heinemann, L, Simpson, GR, Annels, NE, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ and Pandha, HS (2010) The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis MOLECULAR THERAPY, 18 (12). pp. 2085-2093.

Ismail, M, Morgan, R, Harrington, K, Davies, J and Pandha, H (2010) Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model CRYOBIOLOGY, 61 (3). pp. 268-274.

Comins, C, Spicer, J, Protheroe, A, Roulstone, V, Twigger, K, White, CM, Vile, R, Melcher, A, Coffey, MC, Mettinger, KL, Nuovo, G, Cohn, DE, Phelps, M, Harrington, KJ and Pandha, HS (2010) REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer CLINICAL CANCER RESEARCH, 16 (22). pp. 5564-5572.

Anesti, A-M, Simpson, GR, Price, T, Pandha, HS and Coffin, RS (2010) Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo BMC CANCER, 10, ARTN 4.

Daniels, TR, Neacato, II, Rodriguez, JA, Pandha, HS, Morgan, R and Penichet, ML (2010) Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells LEUKEMIA, 24 (9). pp. 1555-1565.

Michael, A, Relph, K and Pandha, H (2010) Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents. International Journal of Cancer, 127 (6). pp. 1251-1258.

Hingorani, M, White, CL, Zaidi, S, Pandha, HS, Melcher, AA, Bhide, SA, Nutting, CM, Syrigos, KN, Vile, RG, Vassaux, G and Harrington, KJ (2010) Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair MOLECULAR THERAPY, 18 (9). pp. 1599-1605.

Lunt, C, Barber, N, Montgomery, A, Kalsi, V, Parker, T, Michael, A, Pandha, H and Hindley, R (2010) CYTOREDUCTIVE NEPHRECTOMY IN THE TYROKINASE INHIBITOR ERA J ENDOUROL, 24. A303-A303.

Pencavel, T, Seth, R, Hayes, A, Melcher, A, Pandha, H, Vile, R and Harrington, KJ (2010) Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow? GENE THERAPY, 17 (8). pp. 949-960.

Harrington, KJ, Karapanagiotou, EM, Roulstone, V, Twigger, KR, White, CL, Vidal, L, Beirne, D, Prestwich, R, Newbold, K, Ahmed, M, Thway, K, Nutting, CM, Coffey, M, Harris, D, Vile, RG, Pandha, HS, DeBono, JS and Melcher, AA (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077.

Gabitass, RF, Annels, NE, Pandha, HS and Middleton, AW (2010) Prevalence and prognostic significance of myeloid-derived suppressor cells and regulatory T cells in pancreatic and esophagogastric cancer JOURNAL OF CLINICAL ONCOLOGY, 28 (15).

Karapanagiotou, EM, Chester, JD, Pandha, HS, Gill, GM, Coffey, MC, Mettinger, K and Harrington, KJ (2010) A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN) JOURNAL OF CLINICAL ONCOLOGY, 28 (15).

Kottke, T, Hall, G, Pulido, J, Diaz, RM, Thompson, J, Chong, H, Selby, P, Coffey, M, Pandha, H, Chester, J, Melcher, A, Harrington, K and Vile, R (2010) Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice JOURNAL OF CLINICAL INVESTIGATION, 120 (5). pp. 1551-1560.

Harrington, KJ, Vile, RG, Melcher, A, Chester, J and Pandha, HS (2010) Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics CYTOKINE & GROWTH FACTOR REVIEWS, 21 (2-3). pp. 91-98.

John, J, Ismail, M, Riley, C, Askham, J, Morgan, R, Melcher, A and Pandha, H (2010) Differential effects of Paclitaxel on dendritic cell function BMC IMMUNOLOGY, 11, ARTN 14.

Morgan, Richard, Plowright, L, Harrington, KJ, Michael, Agnieszka and Pandha, Hardev (2010) Targeting HOX and PBX transcription factors in ovarian cancer BMC CANCER, 10, ARTN 8.

Hingorani, M, Spitzweg, C, Vassaux, G, Newbold, K, Melcher, A, Pandha, H, Vile, R and Harrington, K (2010) The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery CURR CANCER DRUG TAR, 10 (2). pp. 242-267.

Michael, A, John, J, Meyer, B and Pandha, H (2010) Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium THESCIENTIFICWORLDJOURNAL, 10. pp. 393-401.

Prestwich, RJ, Errington, F, Diaz, RM, Pandha, HS, Harrington, KJ, Melcher, AA and Vile, RG (2009) The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon HUMAN GENE THERAPY, 20 (10). pp. 1119-1132.

Ismail, M, Morgan, R, Harrington, K, Davies, J and Pandha, H (2009) Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model CRYOBIOLOGY, 59 (2). pp. 207-213.

Prestwich, RJ, Errington, F, Steele, LP, Ilett, EJ, Morgan, RSM, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus JOURNAL OF IMMUNOLOGY, 183 (7). pp. 4312-4321.

Pandha, Hardev, Heinemann, Lucy, Simpson, Guy, Melcher, A, Prestwich, R, Errington, F, Coffey, M, Harrington, KJ and Morgan, Richard (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Clinical Cancer Research, 15 (19). pp. 6158-6166.

Derhovanessian, E, Adams, V, Haehnel, K, Groeger, A, Pandha, H, Ward, S and Pawelec, G (2009) Pretreatment frequency of circulating IL-17(+)CD4(+) T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients INTERNATIONAL JOURNAL OF CANCER, 125 (6). pp. 1372-1379.

Prestwich, RJ, Ilett, EJ, Errington, F, Diaz, RM, Steele, LP, Kottke, T, Thompson, J, Galivo, F, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication CLINICAL CANCER RESEARCH, 15 (13). pp. 4374-4381.

Ismail, M, Bokaee, S, Morgan, R, Davies, J, Harrington, KJ and Pandha, H (2009) Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy (vol 100, pg 1889, 2009) BRITISH JOURNAL OF CANCER, 101 (3). p. 549.

Ismail, M, Bokaee, S, Davies, J, Harrington, KJ and Pandha, H (2009) Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy BRITISH JOURNAL OF CANCER, 100 (12). pp. 1889-1895.

Pandha, H, Melcher, A, Harrington, K and Vile, R (2009) Oncolytic Viruses: Time to Compare, Contrast, and Combine? MOLECULAR THERAPY, 17 (6). pp. 934-935.

Ilett, EJ, Prestwich, RJ, Kottke, T, Errington, F, Thompson, JM, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Vile, RG and Melcher, AA (2009) Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity GENE THERAPY, 16 (5). pp. 689-699.

Pandha, H, D'Ambrosio, C, Heenan, S, Hyde, N, Di Palma, S, Nutting, C, Relph, K and Harrington, K (2009) Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients CLINICAL ONCOLOGY, 21 (4). pp. 363-364.

Michael, A, Syrigos, K and Pandha, H (2009) Prostate cancer chemotherapy in the era of targeted therapy PROSTATE CANCER AND PROSTATIC DISEASES, 12 (1). pp. 13-16.

Prestwich, RJ, Scott, KJ, Brown, J, Harnden, P, Whelan, P, Cartledge, J, O'Donnell, D, Pandha, HS, Selby, PJ, Banks, RE, Merrick, AE and Melcher, AA (2009) The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma BJU INTERNATIONAL, 103 (6). pp. 740-746.

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, H and Pandha, H (2009) NOVEL INTRAVESICAL THERAPY FOR NON MUSCLE INVASIVE BLADDER CANCER: COMBINATION OF A FUSOGENIC GLYCOPROTEIN, PRO-DRUG ACTIVATION AND ONCOLYTIC HERPES SIMPLEX VIRUS EUR UROL SUPPL, 8 (4). p. 196.

Plowright, L, Harrington, KJ, Pandha, HS and Morgan, R (2009) HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer) BRITISH JOURNAL OF CANCER, 100 (3). pp. 470-475.

Agrawal, VK, Copeland, KM, Barbachano, Y, Rahim, A, Seth, R, White, CL, Hingorani, M, Nutting, CM, Kelly, M, Harris, P, Pandha, H, Melcher, AA, Vile, RG, Porter, C and Harrington, KJ (2009) Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery GENE THERAPY, 16 (1). pp. 78-92.

Plowright, L, Harrington, K, Pandha, HS and Morgan, R (2009) HOX transcription factors are potential therapeutic targets in non-small cell lung cancer British Journal of Cancer.

Koropouli, E, Manolopoulus, L, Pandha, H and Syrigos, KN (2009) The biological role of mTOR in the pathogenesis of solid tumors: An overview Current Enzyme Inhibition, 5 (1). pp. 51-65.

Hingorani, M, White, CL, Merron, A, Peerlinck, I, Gore, ME, Slade, A, Scott, SD, Nutting, CM, Pandha, HS, Melcher, AA, Vile, RG, Vassaux, G and Harrington, KJ (2008) Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors CANCER RESEARCH, 68 (23). pp. 9771-9778.

Yap, TA, Brunetto, A, Pandha, H, Harrington, K and de Bono, JS (2008) Reovirus therapy in cancer: has the orphan virus found a home? EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (12). pp. 1925-1935.

Prestwich, RJ, Errington, F, Ilett, EJ, Morgan, RSM, Scott, KJ, Kottke, T, Thompson, J, Morrison, EE, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2008) Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity CLINICAL CANCER RESEARCH, 14 (22). pp. 7358-7366.

Vidal, L, Pandha, HS, Yap, TA, White, CL, Twigger, K, Vile, RG, Melcher, A, Coffey, M, Harrington, KJ and DeBono, JS (2008) A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer CLINICAL CANCER RESEARCH, 14 (21). pp. 7127-7137.

Shears, L, Plowright, L, Harrington, K, Pandha, HS and Morgan, R (2008) Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P J UROLOGY, 180 (5). pp. 2196-2201.

Alamara, C, Karapanagiotou, EM, Tourkantonis, I, Xyla, V, Maurer, CC, Lykourinas, M, Pandha, H and Syrigos, KN (2008) Renal oncocytoma: a case report and short review of the literature. Eur J Intern Med, 19 (7). e67-e69.

Prestwich, RJ, Harrington, KJ, Pandha, HS, Vile, RG, Melcher, AA and Errington, F (2008) Oncolytic viruses: a novel form of immunotherapy EXPERT REVIEW OF ANTICANCER THERAPY, 8 (10). pp. 1581-1588.

Errington, F, White, CL, Twigger, KR, Rose, A, Scott, K, Steele, L, Ilett, LJ, Prestwich, R, Pandha, HS, Coffey, M, Selby, P, Vile, R, Harrington, KJ and Melcher, AA (2008) Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma GENE THERAPY, 15 (18). pp. 1257-1270.

Comins, C, Heinemann, L, Harrington, K, Melcher, A, De Bono, J and Pandha, H (2008) Reovirus: Viral therapy for cancer 'as nature intended' CLINICAL ONCOLOGY, 20 (7). pp. 548-554.

Harrington, KJ, Melcher, A, Vassaux, G, Pandha, HS and Vile, RG (2008) Exploiting synergies between radiation and oncolytic viruses CURRENT OPINION IN MOLECULAR THERAPEUTICS, 10 (4). pp. 362-370.

Hingorani, M, White, CL, Zaidi, S, Merron, A, Peerlinck, I, Gore, ME, Nutting, CM, Pandha, HS, Melcher, AA, Vile, RG, Vassaux, G and Harrington, KJ (2008) Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy CLINICAL CANCER RESEARCH, 14 (15). pp. 4915-4924.

Papaetis, GS, Karapanagiotou, LM, Pandha, H and Syrigos, KN (2008) Targeted therapy for advanced renal cell cancer: Cytokines and beyond CURRENT PHARMACEUTICAL DESIGN, 14 (22). pp. 2229-2251.

White, CL, Twigger, KR, Vidal, L, De Bono, JS, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, RG, Melcher, AA, Pandha, HS and Harrington, KJ (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial GENE THERAPY, 15 (12). pp. 911-920.

Pandha, HS, Protheroe, A, Wylie, J, Parker, C, Chambers, J, Bell, S and Munzert, G (2008) An open label phase II trial of BI 2536, a novel Plk1 inhibitor, in patients with metastatic hormone refractory prostate cancer (HRPC) JOURNAL OF CLINICAL ONCOLOGY, 26 (15).

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Havranek, EG, Labarthe, M-C, Ward, S, Anderson, CJ, Whelan, MA and Pandha, H (2008) A novel murine model of allogeneic vaccination against renal cancer BJU INTERNATIONAL, 101 (9). pp. 1165-1169.

White, CL, Menghistu, T, Twigger, KR, Searle, PF, Bhide, SA, Vile, RG, Melcher, AA, Pandha, HS and Harrington, KJ (2008) Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo GENE THERAPY, 15 (6). pp. 424-433.

Twigger, K, Vidal, L, White, CL, De Bono, JS, Bhide, S, Coffey, M, Thompson, B, Vile, RG, Heinemann, L, Pandha, HS, Errington, F, Melcher, AA and Harrington, KJ (2008) Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy CLINICAL CANCER RESEARCH, 14 (3). pp. 912-923.

Qiao, J, Wang, H, Kottke, T, White, C, Twigger, K, Diaz, RM, Thompson, J, Selby, P, de Bono, J, Melcher, A, Pandha, H, Coffey, M, Vile, R and Harrington, K (2008) Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus CLINICAL CANCER RESEARCH, 14 (1). pp. 259-269.

Prestwich, RJ, Errington, F, Harrington, KJ, Pandha, HS, Selby, P and Melcher, A (2008) Oncolytic viruses: do they have a role in anti-cancer therapy? Clin Med Oncol, 2. pp. 83-96.

Gore, ME, Nutting, CM, Pandha, HS, Melcher, AA, Vile, RG and Harrington, KJ (2008) T-cell responses to survivin in cancer patients undergoing radiation therapy Clinical Cancer Research, 14 (15). p. 4883.

Plowright, L, Shears, L, Pandha, H and Morgan, R (2007) Disrupting the interaction between Hox and PBX causes apoptotic cell death and reduces in vivo proliferation of a non-small cell lung cancer model MOLECULAR CANCER THERAPEUTICS, 6 (12). 3504S-3504S.

Harris, D, Vidal, L, Melcher, A, Newbold, K, Anthony, A, Karavasilis, V, Agarwal, R, White, C, Twigger, K, Coffey, M, Mettinger, K, Thompson, B, Pandha, H, De-Bono, J and Harrington, K (2007) A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies. MOLECULAR CANCER THERAPEUTICS, 6 (12). 3458S-3458S.

Michael, A, Politi, E, Havranek, E, Corbishley, C, Karapanagiotou, L, Anderson, C, Relph, K, Syrigos, KN and Pandha, H (2007) Prognostic significance of erythropoietin expression in human renal cell carcinoma BJU INTERNATIONAL, 100 (2). pp. 291-294.

Morgan, R, Pirard, PM, Shears, L, Sohal, J, Pettengell, R and Pandha, HS (2007) Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma CANCER RESEARCH, 67 (12). pp. 5806-5813.

Lord, R, Nair, S, Schache, A, Spicer, J, Somaihah, N, Khoo, V and Pandha, H (2007) Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study JOURNAL OF UROLOGY, 177 (6). pp. 2136-2140.

Pandha, H, Rigg, A, John, J and Lemoine, N (2007) Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 148 (1). pp. 127-135.

Dalgleish, A and Pandha, H (2007) Tumor antigens as surrogate markers and targets for therapy and vaccines ADVANCES IN CANCER RESEARCH, VOL 96, 96. pp. 175-190.

Morgan, R and Pandha, HS (2007) Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma Cancer Research, 67 (12). pp. 5806-5813.

Quatan, N, Meyer, B, Bailey, M and Pandha, H (2006) Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy PROSTATE CANCER AND PROSTATIC DISEASES, 9 (4). pp. 420-425.

Hu, JC, Coffin, RS, Graham, NJ, Groves, N, Guest, PJ, Harrington, KJ, James, ND, Love, CA, McNeish, I, Medley, LC, Michael, A, Nutting, CM, Pandha, HS, Shorrock, CA, Simpson, J, Steiner, J, Steven, NM, Wright, D and Coombes, RC (2006) A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor Clin Cancer Res, 12 (22). pp. 6737-6747.

Pandha, H, Birchall, L, Meyer, B, Wilson, N, Relph, K, Anderson, C and Harrington, K (2006) Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines JOURNAL OF UROLOGY, 176 (5). pp. 2255-2261.

Morgan, R, Fairfax, B and Pandha, HS (2006) Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK MOLECULAR CANCER, 5, ARTN 5.

Yap, TA, Vidal, L, Pandha, H, Spicer, J, Digue, L, Coffey, M, Thompson, B, Kaye, SB, Harrington, KJ and De-Bono, JS (2006) A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer EJC SUPPLEMENTS, 4 (12). p. 108.

Chowdhury, S and Pandha, H (2006) Targeting renal cell carcinoma CLINICAL ONCOLOGY, 18 (7). pp. 511-512.

Relph, KL, Michael, A, Havranek, E, Anderson, C, Polychronis, A, Corbishley, C and Pandha, H (2006) Prognostic impact of P53, EGFR and HER2/Neu proteins on renal cell carcinoma Internet Journal of Urology.

Relph, KL, Harrington, KJ and Pandha, H (2005) Adenoviral strategies for the gene therapy of cancer SEMINARS IN ONCOLOGY, 32 (6). pp. 573-582.

Spicer, J, Plunkett, T, Somaiah, N, Chan, S, Kendall, A, Bolunwu, N and Pandha, H (2005) Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer PROSTATE CANCER AND PROSTATIC DISEASES, 8 (4). pp. 364-368.

Michael, A, Ball, G, Quatan, N, Wushishi, F, Russell, N, Whelan, J, Chakraborty, P, Leader, D, Whelan, M and Pandha, H (2005) Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables Clin Cancer Res, 11 (12). pp. 4469-4478.

Relph, KL, Harrington, K and Pandha, H (2004) Gene Therapy using viral vectors; recent developments and current status in the United Kingdom British Medical Journal.

Book Section

Annels, NE and Pandha, H (2013) Immunotherapy In: Prostate Cancer: A Comprehensive Perspective. UNSPECIFIED, pp. 925-934. ISBN 9781447128649

Pandha, HS, Harrington, KJ and Vile, RG (2008) Poxviruses as immunomodulatory cancer therapeutics. In: Viral Therapy of Cancer. UNSPECIFIED. ISBN 0470019220

Conference or Workshop Item

Michael, A, McGrath, S, Annels, N, Denyer, M, Morgan, R and Pandha, H (2015) Engrailed 2 protein (EN2) as a novel biomarker in epithelial ovarian cancer In: European Cancer Congress, 2015 - ?, Vienna, AUSTRIA.

Vogelzang, NJ, Beer, TM, Bartunkova, J, Kuklk, R, Miller, K, Oh, WK, Oudard, S, Pandha, HS, Sartor, AO, Spisek, R, Borgstein, NG and Gerritsen, WR (2015) Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer. In: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015-05-29 - 2015-06-02, Chicago, IL.

Rajani, K, Shim, K, Parrish, C, Ilett, L, Kottke, T, Pulido, J, Thompson, J, Pandha, H, Harrington, K, Melcher, A, Errington, F, Diaz, R, Coffey, M, Zaidi, S and Vile, R (2015) Combination Therapy of Reovirus and PD-1 Blockade Effectively Establishes Tumor Control Via Innate and Adaptive Immune Responses In: 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2015-05-13 - 2015-05-16, New Orleans, LA.

Jebar, A, Bentham, M, Errington-Mais, F, Scott, K, Peckham-Cooper, A, Dave, R, Toogood, G, Swinson, D, Ralph, C, Anthoney, A, Coffey, M, Harrington, K, Pandha, H, Vile, R, Selby, P, Melcher, A and Griffin, S (2014) Combined anti-viral and anti-tumour therapy for virus-associated liver cancer In: 8th International Conference on Oncolytic Virus Therapeutics, 2014-04-10 - 2014-04-13, Lincoln Coll & Examinat Sch, Oxford, ENGLAND.

Simpson, GR, Ajaz, M, Launchbury, FA, Bolton, G, Melcher, AA, Harrington, KJ, Au, GG, Shafren, DR and Pandha, HS (2014) Major synergy between Coxsackievirus A21 (CAVATAK (TM)) and radiotherapy or chemotherapy in bladder cancer In: 8th International Conference on Oncolytic Virus Therapeutics, 2014-04-10 - 2014-04-13, Lincoln Coll & Examinat Sch, Oxford, ENGLAND.

Bolton, GC, Simpson, GR, Coffey, M, Harrington, K, Morgan, R, Annels, N, Launchbury, FA, Ajaz, M and Pandha, H (2014) Resistance to Oncolytic Reovirus is associated with high expression of Yes-Associated Protein-1 (YAP-1) in Head and Neck Cancer In: 8th International Conference on Oncolytic Virus Therapeutics, 2014-04-10 - 2014-04-13, Lincoln Coll & Examinat Sch, Oxford, ENGLAND.

Simpson, GR, Annels, N, Ajaz, M, Launchbury, F, Bolton, G, Melcher, AA, Harrington, KJ, Au, G, Shafren, D and Pandha, H (2014) Major synergy between Coxsackievirus A21 (CAVATAK (TM)) and radiotherapy or chemotherapy in bladder cancer In: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2014-11-18 - 2014-11-21, European Org Res & Treatment Canc, Barcelona, SPAIN.

Brend, T, Kelly, Z, Ajaz, M, Morgan, R, Pandha, H and Short, SC (2014) THERAPEUTIC POTENTIAL OF TARGETING HOX PROTEIN FUNCTION IN GLIOBLASTOMA In: 11th Congress of the European-Association-of-Neuro-Oncology, 2014-10-09 - 2014-10-12, Turin, ITALY.

Javed, S, Morgan, R, Hindley, R, Bott, S, Eden, C, Pandha, H and Langley, S (2014) Urinary engrailed-2 levels in healthy volunteers, patients on active surveillance and following radical prostate cancer treatment In: Annual Scientific Meeting of the British-Association-of-Urological-Surgeons (BAUS), 2014-06-23 - 2014-06-26, Liverpool, ENGLAND.

Enting, D, Lannitto, ML, Pandha, HS, Eberi, M, Chowdhury, S and Hayday, AC (2014) Effects of concomitant therapies on gamma delta T-cell responses to zoledronate in patients with advanced prostate cancer In: 50th Annual Meeting of the American-Society-of-Clinical-Oncology, 2014-05-30 - 2014-06-03, Chicago, IL.

Crabb, SJ, Douglas, J, Annels, NE, Morgan, R, Packham, G and Pandha, HS (2014) Engrailed-2 (EN2) protein expression and prognosis in bladder cancer following radical cystectomy (RC). In: 50th Annual Meeting of the American-Society-of-Clinical-Oncology, 2014-05-30 - 2014-06-03, Chicago, IL.

Jebar, A, West, E, Scott, K, Thomson, S, Corns, R, Coffey, MC, Rose, A, Nuovo, G, Ryan, M, Errington-Mais, F, Ralph, C, Twelves, C, Griffin, S, Harrington, KJ, Pandha, HS, Donnely, O, Selby, PJ, Vile, R, Short, S and Melcher, A (2014) Oncolytic wild-type reovirus infection in brain tumors following intravenous administration in patients. In: 50th Annual Meeting of the American-Society-of-Clinical-Oncology, 2014-05-30 - 2014-06-03, Chicago, IL.

Zaidi, S, Blanchard, M, Shim, K, Ilett, E, Kottke, T, Thompson, J, Celis, E, Pandha, H, Selby, P, Melcher, A, Harrington, K and Vile, R (2014) Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Ilett, E, Kottke, T, Donnelly, O, Thompson, J, Willmon, C, Diaz, R, Zaidi, S, Coffey, M, Selby, P, Harrington, K, Pandha, H, Melcher, A and Vile, R (2014) Direct, Cytokine-Conditioned, In Vivo Cell Loading for Systemic Delivery of Oncolytic Viruses In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Alonso-Camino, V, Rajani, K, Kottke, T, Rommelfanger-Konkol, D, Zaidi, S, Thompson, J, Pulido, J, Ilett, L, Selby, P, Pandha, H, Melcher, A, Harrington, K, Diaz, R and Vile, R (2014) The Profile of Tumor Antigens Which Can Be Targeted By Immunotherapy Depends Upon the Tumor's Anatomical Site In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Enting, D, Iannitto, ML, Binda, E, Eberl, M, Pandha, H and Hayday, A (2013) Effects of concomitant therapies on gd T cell responses to zoledronate in patients with advanced prostate cancer In: Annual Congress of the British-Society-for-Immunology, 2013-12-02 - 2013-12-05, Liverpool, ENGLAND.

Kottke, T, Donnelly, O, Ilett, E, Thompson, J, Diaz, R, Coffey, M, Selby, P, Pandha, H, Harrington, K, Melcher, A and Vile, R (2013) In Vivo Expansion of a Recipient Population of Cell Carriers Allows for Highly Effective Systemic Delivery of Oncolytic Reovirus Even in the Presence of Neutralizing Antibody In: 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2013-05-15 - 2013-05-18, Salt Lake City, UT.

Boisgerault, N, Pulido, J, Kottke, T, Donnelly, O, Celis, E, Thompson, J, Diaz, R, Harrington, K, Pandha, H, Selby, P, Melcher, A and Vile, R (2013) Tumor Recurrences Share Immunogenic Antigens across Both Tumor Types and Primary Treatments Which Can Be Therapeutically Targeted with VSV-cDNA Libraries In: 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2013-05-15 - 2013-05-18, Salt Lake City, UT.

Kottke, T, Donnelly, O, Boisgerault, N, Diaz, R, Rommelfanger-Konkol, D, Pulido, J, Thompson, J, Mukhopadhyay, D, Knutson, K, Behrens, M, Kaspar, R, Coffey, M, Selby, P, Harrington, K, Melcher, A, Pandha, H and Vile, R (2013) Tumor Relapse Is Associated with an Innate Immune Resistant Phenotype across Tumor and Treatment Types Which Can Be Targeted with Rational Second Line Therapies In: 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2013-05-15 - 2013-05-18, Salt Lake City, UT.

Javed, S, Pandha, H, Morgan, R, Bott, S, Eden, C and Langley, S (2013) Urinary Engrailed-2 (EN2) levels and their correlation with tumour volume and pathological tumour stage in men undergoing radical prostatectomy for prostate cancer In: Annual Scientific Meeting of the British-Association-of-Urological-Surgeons (BAUS), 2013-06-17 - 2013-06-20, Manchester, ENGLAND.

Gray, S, Metcalf, S, Boxall, A, Middleton, G, Bagwan, I, Pandha, H and Morgan, R (2013) The chorio-allantoicmembrane (CAM) model for testing HOX gene antagonism in pancreatic cancer In: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2013-04-06 - 2013-04-10, Washington, DC.

Annels, NE, Simpson, GR, Bokaee, S, Riley, C, Denyer, M, Pandha, H and Morgan, R (2012) Modulation of Regulatory T Cells by Targeting The NFAT-FOXP3 Protein: Protein Interaction In: 27th Annual Scientific Meeting of the Society-for-Immunotherapy-of-Cancer (SITC), 2012-10-24 - 2012-10-28, North Bethesda, MD.

Kelly, Z, Pandha, H, Madhuri, K, Morgan, R and Michael, A (2012) HOX GENE EXPRESSION IN OVARIAN CANCER In: 37th Congress of the European-Society-for-Medical-Oncology (ESMO), 2012-09-28 - 2012-10-02, Vienna, AUSTRIA.

Kelly, Z, Pandha, H, Morgan, R and Michael, A (2012) HXR9 AND PARP INHIBITION -A NOVEL THERAPEUTIC IN OVARIAN CANCER In: 37th Congress of the European-Society-for-Medical-Oncology (ESMO), 2012-09-28 - 2012-10-02, Vienna, AUSTRIA.

Ravaud, A, Motzer, RJ, Pandha, H, Staehler, M, George, DJ, Pantuck, A, Patel, A, Gerletti, P, Chen, L and Patard, J (2012) SUNITINIB TREATMENT OF RENAL ADJUVANT CANCER (S-TRAC): A RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF SUNITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RENAL CELL CARCINOMA (RCC) In: 37th Congress of the European-Society-for-Medical-Oncology (ESMO), 2012-09-28 - 2012-10-02, Vienna, AUSTRIA.

Eisenberger, MA, Hardy-Bessard, A-C, Mourey, L, Mainwaring, PN, Ford, D, Shapiro, JD, Carles, J, Ng, S, Gil, T, Alekseev, B, Ivanov, S, Facchini, T, Legouffe, E, Apolikhin, O, Pandha, HS, Beeker, A, Karyakin, O, Zhang, W, Chadjaa, M and De Bono, JS (2012) Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen In: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012-06-01 - 2012-06-06, Chicago, IL.

Killick, E, Morgan, R, Launchbury, F, Annels, NE, Bancroft, E, Page, E, Castro, E, Kote-Jarai, Z, Eeles, RA and Pandha, HS (2012) Detecting prostate cancer in BRCA1 and BRCA2 mutation carriers: A role for EN2? In: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012-06-01 - 2012-06-06, Chicago, IL.

McGrath, S, Annels, NE, Madhuri, TK, Haagsma, B, Larbi, ED, Pandha, HS and Michael, A (2012) Engrailed protein: A cancer-specific marker in epithelial ovarian cancer In: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012-06-01 - 2012-06-06, Chicago, IL.

Kottke, T, Donnelly, O, Boisgerault, N, Diaz, R, Thompson, J, Chester, J, Pandha, H, Harrington, K, Melcher, A and Vile, R (2012) Characterization of the Mechanisms of Tumor Dormancy and Recurrence Following Front Line Immuno-, Viro- or Suicide Gene-, Therapy In: 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2012-05-16 - 2012-05-19, Philadelphia, PA.

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, AH and Pandha, H (2011) Update on a novel intravesical therapy for non muscle invasive bladder cancer: Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic herpes simplex virus In: Annual Meeting of the Society-of-Academic-and-Research-Surgeons, 2010-01-06 - 2010-01-07, Royal Free Hosp, London, ENGLAND.

Ismail, MI, Bokaee, S, Annels, N, Davies, J and Pandha, H (2011) Predominance of CD8 T cell infiltration coincides with reciprocal reduction in regulatory T cells following prostate cryotherapy In: Annual Meeting of the Society-of-Academic-and-Research-Surgery, 2011-01-05 - 2011-01-06, Royal Coll Surgery, Dublin, IRELAND.

Michael, A, Zylstra, J and Pandha, H (2011) The sun study-a biobank of sequential blood samples from patients with prostate cancer In: Annual Meeting of the Society-of-Academic-and-Research-Surgery, 2011-01-05 - 2011-01-06, Royal Coll Surgery, Dublin, IRELAND.

Roberts, A, Serrano, M, Vantourout, P, Dieli, F, Pandha, H and Hayday, AC (2010) Expansion of autologous human V gamma 9V delta 2 T cells ex vivo: potential for adoptive T cell therapy of prostate cancer In: Annual Congress of the British-Society-for-Immunology, 2010-12-06 - 2010-12-10, Liverpool, ENGLAND.

Binda, E, Perez, SM, Pandha, H, Eberl, M and Hayday, A (2010) Monitoring the immunological effects of bisphosphonates in different treatment scenarios In: Annual Congress of the British-Society-for-Immunology, 2010-12-06 - 2010-12-10, Liverpool, ENGLAND.

Annels, NE, Riley, C, Bokaee, S, Denyer, M, Simpson, GR and Pandha, H (2010) EN2: A Novel Immunotherapeutic Target for Melanoma

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, H and Pandha, H (2010) NOVEL INTRAVESICAL THERAPY FOR NON MUSCLE INVASIVE BLADDER CANCER USING A GENETICALLY MODIFIED ONCOLYTIC HERPES SIMPLEX VIRUS

Ismail, M, Morgan, R, Davies, J and Pandha, H (2009) Inhibition of the aquaporin water channels (AQPs) increases the sensitivity of DU145 cells to cryotherapy In: Annual Meeting of the British-Association-of-Urological-Surgeons, 2009-06-22 - 2009-06-25, Glasgow, SCOTLAND.

Karapanagiotou, E, Pandha, HS, Hall, G, Chester, J, Melcher, A, Coffey, M, de Bono, J, Gore, ME, Nutting, CM and Harrington, KJ (2009) Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

Rudman, SM, Comins, C, Mukherji, D, Coffey, M, Mettinger, K, Protheroe, A, Harrington, KJ, Pandha, H and Spicer, JF (2009) Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

Ismail, M, Kevin, H, Morgan, R, Davies, J and Pandha, H (2009) ENHANCING PROSTATE CANCER CRYOTHERAPY USING TUMOUR NECROSIS FACTOR RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) SENSITISATION IN A NOVEL IN VITRO MODEL In: 104th Annual Meeting of the American-Urological-Association, 2009-04-25 - 2009-04-30, Chicago, IL.

Ismail, M, Morgan, R, Davies, J and Pandha, H (2009) INHIBITION OF THE AQUAPORIN WATER CHANNELS INCREASES THE SENSITIVITY OF PROSTATE CANCER CELLS TO FREEZING INJURY. In: 104th Annual Meeting of the American-Urological-Association, 2009-04-25 - 2009-04-30, Chicago, IL.

Comins, C, Spicer, J, Protheroe, A, Mukherji, D, Coffey, M, Thompson, B, Harrington, K and Pandha, H (2008) A Phase I Study to Evaluate Systemic Wild-type Reovirus (REOLYSIN)(R) in Combination With Docetaxel in Patients With Advanced Malignancies In: 23rd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2008-10-31 - 2008-11-02, San Diego, CA.

Karapanagiotou, E, Pandha, H, Hall, G, Chester, J, Melcher, A, De Bono, J, Gore, M, Nutting, C and Harrington, K (2008) Phase I Trial of Oncolytic Reovirus (Reolysin) in Combination With Carboplatin/Paclitaxel in Patients With Advanced Solid Cancers In: 23rd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2008-10-31 - 2008-11-02, San Diego, CA.

Heinemann, L, Kottke, T, Vile, R, Coffey, MC, Harrington, K, Melcher, A and Pandha, HS (2008) Synergistic Anti-Tumor Activity of Oncolytic Reovirus and Docetaxel in a PC-3 Prostate Cancer Mouse Model In: 23rd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2008-10-31 - 2008-11-02, San Diego, CA.

Simpson, GR, Horvath, A, Harrington, K, Coffin, RS and Pandha, H (2008) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer In: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2008-10-21 - 2008-10-24, Geneva, SWITZERLAND.

Heinemann, L, Simpson, G, Harrington, K, Melcher, A, Coffey, MC and Pandha, HS (2008) Synergistic anti-tumour activity of oncolytic Reovirus and cisplatin in a B16.F10 mouse melanoma model In: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2008-10-21 - 2008-10-24, Geneva, SWITZERLAND.

Ismail, M, Morgan, R, Davies, J and Pandha, H (2008) Immunoregulatory effects of cryo-treated prostate cancer cells on human dendritic cells using a novel in vitro cryotherapy model In: 103rd Annual Meeting of the American-Urological-Association, 2008-05-17 - ?, Orlando, FL.

Meyer, B, Denyer, M, Morgan, R and Pandha, H (2007) Cellular effects of phosphoramide mustard, the active metabolite of cyclophosphamide, on naturally-occuring human CD4(+) CD25(+) regulatory T cells In: 22nd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2007-11-02 - 2007-11-04, Boston, MA.

Balls, G, Quatan, N, Michael, A, Lancashire, L, Adams, V, Hoffman, B, Pfirschke, C, Russell, N, Whelan, M and Pandha, H (2007) Immunological response patterns correlate with clinical outcome after allogeneic vaccination in hormone resistant prostate cancer metastatic to bone In: 22nd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2007-11-02 - 2007-11-04, Boston, MA.

Ismail, M, Ahmed, S, Laing, R, Nigam, R, Langley, S, Pandha, H and Davies, J (2007) Antibody immunity to prostate cancer specific antigen in the serum of patients having cryotherapy or brachytherapy treatment compared to healthy volunteers In: Annual Meeting of the British-Association-of-Urological-Surgeons, 2004-06-18 - 2007-06-22, Glasgow, SCOTLAND.

Verbeke, CS, Hamdan, S, Booth, J, Pandha, HS and Blair, GE (2006) Limited expression of the Coxsackie and Adenovirus Receptor in pancreatic cancer may reduce suitability of adenoviral gene therapy In: 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland, 2006-07-04 - 2006-07-07, Manchester, ENGLAND.

Vidal, L, Pandha, H, Spicer, J, Harrington, KJ, Allen, S, Leader, D, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2006) A phase I study of reolysin given intravenously to patients with advanced malignancies. In: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, 2006-06-02 - 2006-06-06, Atlanta, GA.

Vidal, L, Twigger, K, White, C, Coffey, M, Thompson, B, De-Bono, J, Pandha, HS, Melcher, A, Kaye, S and Harrington, KJ (2005) Reovirus enhances radiation cytotoxicity in vitro and in vivo. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

Vidal, L, Pandha, H, Harrington, K, Fong, P, Shaw, H, Barrett, M, Leader, D, White, C, Twigger, K, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2005) A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

Michael, A, Riley,, C, Bokaee, S, Denyer, M, Pandha, H and Annels, N EN2: A candidate antigen for the development of targeted therapies in ovarian cancer. In: ASCO, 2011-06-03 - 2011-06-07, Chicago.

Michael, A, Plowright, L, Boxall, A, Bhatt, A, Di Palma, S, Parker, C and Pandha, H Evaluation of EN2 as a urine-based biomarker for prostate cancer. In: ASCO, 2010-06-03 - 2010-06-07, Chicago USA.

Coward, JIG, Larbi, ED, Pandha, H and Michael, A The effect of age on first-line sunitinib treatment in patients with renal cell carcinoma (RCC). In: ASCO, 2011-06-03 - 2011-06-07, Chicago USA.

Book

Pandha, HS, Relph, K and Harrington, K (2008) Treatment of Cancer 5th Edition Chapter Gene Therapy UNSPECIFIED. ISBN 0340912219

Pandha, HS, Harrington, KJ and Vile, RG (2008) Viral Therapy of Cancer John Wiley. ISBN 0470019220

This list was generated on Thu Sep 21 01:47:13 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800